LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Expansion Relay Therapeutics announced a proposed public offering of common stock, indicating potential investment opportunities and a growing market presence.

Investment Boost Allspring Global Investments made a new investment in Relay Therapeutics, indicating confidence in the company's growth prospects and creating potential partnership opportunities.

Cutting-Edge Development Relay Therapeutics is developing GDC-1971, an oral small molecule inhibitor, opening up possibilities for collaboration or licensing deals in the pharmaceutical sector.

Innovative Product Development The launch of initial clinical data for RLY-2608, an investigational allosteric inhibitor, showcases Relay Therapeutics' pipeline strength, presenting potential licensing or co-development opportunities.

Strategic Investment Aigen Investment Management LP recently invested in Relay Therapeutics, reflecting confidence in the company's financial health and potential for further growth, signaling opportunities for strategic partnerships.

Similar companies to Relay Therapeutics

Relay Therapeutics Tech Stack

Relay Therapeutics uses 8 technology products and services including Linkedin Insight Tag, SAS/GRAPH, SAP, and more. Explore Relay Therapeutics's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • SAS/GRAPH
    Business Intelligence
  • SAP
    Customer Relationship Management
  • MySQL
    Database
  • Ionicons
    Font Scripts
  • AngularJS
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Base SAS
    Software As A Service

Media & News

Relay Therapeutics's Email Address Formats

Relay Therapeutics uses at least 1 format(s):
Relay Therapeutics Email FormatsExamplePercentage
FLast@relaytx.comJDoe@relaytx.com
96%
Last@relaytx.comDoe@relaytx.com
3%
FMLast@relaytx.comJMDoe@relaytx.com
1%

Frequently Asked Questions

Where is Relay Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Relay Therapeutics's main headquarters is located at 399 Binney Street 2nd Floor Cambridge, MA 02139 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Relay Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Relay Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Relay Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Relay Therapeutics is a publicly traded company; the company's stock symbol is RLAY.

What is Relay Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Relay Therapeutics's official website is relaytx.com and has social profiles on LinkedIn.

How much revenue does Relay Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Relay Therapeutics's annual revenue reached $35M.

What is Relay Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Relay Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Relay Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Relay Therapeutics has approximately 281 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Data Officer: P. W.Chief People Officer: J. G.Chief Legal Officer: B. A.. Explore Relay Therapeutics's employee directory with LeadIQ.

What industry does Relay Therapeutics belong to?

Minus sign iconPlus sign icon
Relay Therapeutics operates in the Biotechnology Research industry.

What technology does Relay Therapeutics use?

Minus sign iconPlus sign icon
Relay Therapeutics's tech stack includes Linkedin Insight TagSAS/GRAPHSAPMySQLIoniconsAngularJSjQuery MigrateBase SAS.

What is Relay Therapeutics's email format?

Minus sign iconPlus sign icon
Relay Therapeutics's email format typically follows the pattern of . Find more Relay Therapeutics email formats with LeadIQ.

How much funding has Relay Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Relay Therapeutics has raised $200M in funding. The last funding round occurred on Sep 10, 2024 for $200M.

When was Relay Therapeutics founded?

Minus sign iconPlus sign icon
Relay Therapeutics was founded in 2016.
Relay Therapeutics

Relay Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology. By applying these insights, we believe we have a differentiated approach to drug protein targets based on their motion, enabling us to select and advance unique product candidates that can be developed into novel therapies for patients.

Located in Cambridge, Massachusetts, our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. If you're creative, collaborative and passionate about making a difference in the lives of patients, join us!

Section iconCompany Overview

Headquarters
399 Binney Street 2nd Floor Cambridge, MA 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RLAY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
201-500

Section iconFunding & Financials

  • $200M

    Relay Therapeutics has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $200M.

  • $10M$50M

    Relay Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $200M

    Relay Therapeutics has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $200M.

  • $10M$50M

    Relay Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.